AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AZITHROMYCIN 500.000 Mg ;

10 registrations across 1 African market— 10 active

Markets with AZITHROMYCIN 500.000 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
AZATRIBACT
Hard Gelatin Capsules
🇪🇬EgyptRIVA PHARMAactive
INFECTOMYCIN
Film Coated Tablets
🇪🇬EgyptSun pharma Egypt limitedactive
Zalipritz
Lyophilized Powder For Solution For I.V Infusion
🇪🇬EgyptAdvocure Bio Pharmaceuticalsactive
Xithrobiotic 500 mg
Hard Gelatin Capsules
🇪🇬Egyptkahira pharmaceuticals and chemical industriesactive
Ecanobiotic
Film Coated Tablets
🇪🇬EgyptM.N.-EGYPTactive
GIGAZOCIN
Hard Gelatin Capsules
🇪🇬EgyptPioneer Pharmaceutical Industries (Pioneer Pharma)(local under construction)active
AZIMACRON 500 mg
Film Coated Tablets
🇪🇬Egyptsabaa international company for pharmaceutical and chemical industriesactive
INFECTOMYCIN
Film Coated Tablets
🇪🇬EgyptSun pharma Egypt limitedactive
Zalipritz
Lyophilized Powder For Solution For I.V Infusion
🇪🇬EgyptAdvocure Bio Pharmaceuticalsactive
Xithrone
Lyophilized Powder For Solution For I.V Infusion
🇪🇬EgyptAmoun Pharmaceutical Companyactive

AZITHROMYCIN 500.000 Mg ; in Africa — Regulatory Overview

AZITHROMYCIN 500.000 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.